首页> 外文期刊>Archives of pathology & laboratory medicine >Sclerosing hemangioma of the lung.
【24h】

Sclerosing hemangioma of the lung.

机译:肺硬化性血管瘤。

获取原文
获取原文并翻译 | 示例

摘要

We present a brief review of sclerosing hemangioma, an uncommon but histologically distinctive neoplasm of the lung. Based on immunohistochemical and molecular findings, sclerosing hemangioma is thought to be derived from incompletely differentiated respiratory epithelium. Sclerosing hemangiomas typically present as asymptomatic, peripheral, solitary, well-circumscribed lesions in women with a mean age at diagnosis in the fifth decade. Rare cases are reported to have regional lymph node metastases; however, metastases do not appear to affect long-term survival. Histologically, sclerosing hemangioma is characterized by a distinct constellation of findings including 2 epithelial cell types, surface cells and round cells, which form 4 architectural patterns, papillary, sclerotic, solid, and hemorrhagic. Sclerosing hemangioma of the lung is generally considered to be a benign lesion, and surgical excision is curative without the need for additional treatment.
机译:我们目前对硬化性血管瘤(一种罕见但在组织学上独特的肺部肿瘤)进行简要回顾。基于免疫组化和分子发现,硬化性血管瘤被认为是由呼吸道上皮细胞的不完全分化引起的。硬化性血管瘤通常表现为女性的无症状,周围,孤立,界限分明的病变,在诊断的平均年龄为第五个十年。罕见病例有局部淋巴结转移;但是,转移似乎并未影响长期生存。从组织学上讲,硬化性血管瘤的特点是发现的星座不同,包括2种上皮细胞类型,表面细胞和圆形细胞,形成4种结构模式,即乳头状,硬化性,实体性和出血性。肺硬化性血管瘤一般被认为是一种良性病变,手术切除是治愈性的,不需要额外的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号